Sophie E. Davies
Bath, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
DNA methylation-mediated memory of obesity in CD4 T lymphocytes perpetuates immune dysregulation.
Journal: EMBO reports
Published: May 10, 2025
Exercise without Weight Loss Prevents Seasonal Decline in Vitamin D Metabolites: The VitaDEx Randomized Controlled Trial.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 05, 2024
In vitro human skin absorption of ethyl salicylate, pentyl salicylate, and (Z)-3-hexenyl salicylate from topical formulations: Effects on permeation and distribution.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: September 13, 2024
Myths and Methodologies: Standardisation in Human Physiology Research-Should We Control the Controllables?
Journal: International journal of sport nutrition and exercise metabolism
Published: May 09, 2024
Myths and Methodologies: Standardisation in human physiology research-should we control the controllables?
Journal: Experimental physiology
Published: September 28, 2023
ChAdOx1 nCoV-19 vaccination generates spike-specific CD8+ T cells in aged mice.
Journal: Immunology and cell biology
Published: February 20, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Journal: Clinical and experimental immunology
Published: November 01, 2022
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.
Journal: Cell reports. Medicine
Published: July 04, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 18, 2022
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
Journal: EBioMedicine
Published: May 03, 2022
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Journal: Lancet (London, England)
Published: June 24, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026